Κένυα -
Αγγλικά -
Pharmacy and Poisons Board
myhep dvir (daclatasvir and sofosbuvir film-coated tablet
mylan laboratories limited mylan laboratories limited. plot no.564/a/22, - daclatasvir and sofosbuvir film-coated tablets 60… - film-coated tablet - each film-coated tablet contains: daclatasvir… - daclatasvir
Αυστραλία -
Αγγλικά -
Department of Health (Therapeutic Goods Administration)
daklinza daclatasvir (as dihyrochloride) 90 mg tablet blister
bristol-myers squibb australia pty ltd - daclatasvir dihydrochloride -
Ευρωπαϊκή Ένωση -
Αγγλικά -
EMA (European Medicines Agency)
daklinza
bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - hepatitis c, chronic - antivirals for systemic use - daklinza is indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults (see sections 4.2, 4.4 and 5.1). for hcv genotype specific activity, see sections 4.4 and 5.1.,
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
daklinza 30mg tablets
bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 30mg
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
daklinza 60mg tablets
bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 60mg
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
daklinza 90mg tablets
bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 90mg
Ευρωπαϊκή Ένωση -
Αγγλικά -
myHealthbox
daklinza 30 mg film-coated tablets
bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 30 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults
Ευρωπαϊκή Ένωση -
Αγγλικά -
myHealthbox
daklinza 60 mg film-coated tablets
bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 60 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults
Μαλαισία -
Αγγλικά -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
daclavir 60mg film coated tablet
pharmaniaga manufacturing berhad - daclatasvir dihydrochloride -
Τανζανία -
Αγγλικά -
Tanzania Medicinces & Medical Devices Authority
daclavirdin film coated tablets 60 mg
eva pharma for pharmaceuticals and medical appliances, egypt - daclatasvir dihydrochloride - film coated tablets - 60 mg